Non-Canonical Programmed Cell Death in Colon Cancer

Simple Summary Non-canonical PCD is an important player in colon cancer cell suicide. It influences colon cancer in many ways, such as through tumorigenesis, treatment, and prognosis. In this review, we present the mechanism, application, and prospect of different types of non-canonical PCD in colon cancer. Programmed cell death (PCD) is an evolutionarily conserved process of cell suicide that is regulated by various genes and the interaction of multiple signal pathways. Non-canonical programmed cell death (PCD) represents different signaling excluding apoptosis. Colon cancer is the third most incident and the fourth most mortal worldwide. Multiple factors such as alcohol, obesity, and genetic and epigenetic alternations contribute to the carcinogenesis of colon cancer. In recent years, emerging evidence has suggested that diverse types of non-canonical programmed cell death are involved in the initiation and development of colon cancer, including mitotic catastrophe, ferroptosis, pyroptosis, necroptosis, parthanatos, oxeiptosis, NETosis, PANoptosis, and entosis. In this review, we summarized the association of different types of non-canonical PCD with tumorigenesis, progression, prevention, treatments, and prognosis of colon cancer. In addition, the prospect of drug-resistant colon cancer therapy related to non-canonical PCD, and the interaction between different types of non-canonical PCD, was systemically reviewed.

Automated summary

Non-canonical programmed cell death (PCD) plays an important role in colon cancer, influencing its tumorigenesis, treatment, and prognosis. This review examines the mechanisms, applications, and prospects of different types of non-canonical PCD in colon cancer. Various types of non-canonical PCD, including mitotic catastrophe, ferroptosis, pyroptosis, necroptosis, parthanatos, oxeiptosis, NETosis, PANoptosis, and entosis, are involved in the initiation and development of colon cancer. The review summarizes the association of these non-canonical PCD types with tumorigenesis, progression, prevention, treatments, and prognosis of colon cancer, as well as the potential of drug-resistant colon cancer therapy related to non-canonical PCD and the interaction between different types of non-canonical PCD.